{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:49Z","timestamp":1786119409174,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/coc.0b013e3181979093","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T18:46:11Z","timestamp":1269629171000},"page":"144-147","source":"Crossref","is-referenced-by-count":17,"title":["Cetuximab, Paclitaxel, Carboplatin, and Radiation For Head and Neck Cancer"],"prefix":"10.1097","volume":"33","author":[{"given":"Ariel","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dipetrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Wanebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacoub","family":"Puthwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Safran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Ready","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence Tai-Weng","family":"Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiation in patients with advanced nasopharyngeal cancer. Phase III randomized intergroup study 0099.","volume":"16","author":"Al-Sarraf","year":"1988","journal-title":"J Clin Oncol"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.","volume":"34","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractinated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.2000.18.7.1458","article-title":"Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.","volume":"18","author":"Jeremic","year":"2000","journal-title":"J Clin Oncol"},{"key":"R5-8-20210128","first-page":"4322","article-title":"Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.","volume":"53","author":"Fan","year":"1993","journal-title":"Cancer Res"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"27595","DOI":"10.1016\/S0021-9258(18)47026-3","article-title":"Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.","volume":"269","author":"Fan","year":"1994","journal-title":"J Biol Chem"},{"key":"R7-8-20210128","first-page":"1204","article-title":"Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.","volume":"7","author":"Shin","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1200\/JCO.2005.07.119","article-title":"A phase II multicenter study of the anti-epidermal growth 00.23factor receptor (EGFR) monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metasatic and\/or recurrent squamous cell carcinoma of the head and neck (SCCHN).","volume":"23","author":"Basel1ga","year":"2005","journal-title":"J Clin Oncol"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","article-title":"Phase III Randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic\/recurrent head and neck cancer: an Eastern Cooperative Oncology Group Study.","volume":"23","author":"Burtness","year":"2005","journal-title":"J Clin Oncol"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1078-0432.795.11.2","article-title":"The effects of cetuximab alone and in combination with radiation and\/or chemotherapy in ling cancer.","volume":"11","author":"Raben","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R11-8-20210128","first-page":"1935","article-title":"Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.","volume":"59","author":"Huang","year":"1999","journal-title":"Cancer Res"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-230X(08)60959-8","article-title":"Oncogenic basis of radiation resistance.","volume":"61","author":"Kasid","year":"1993","journal-title":"Adv Cancer Res"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous\u2013cell carcinoma of the head and neck.","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2004.00.1792","article-title":"Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.","volume":"24","author":"Pfister","year":"2006","journal-title":"J Clin Oncol"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hed.20700","article-title":"Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: long-term follow-up of Brown University Oncology Group Phase II Study (HN-53).","volume":"30","author":"Chougule","year":"2008","journal-title":"Head Neck"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/107327489600300402","article-title":"Concurrent paclitaxel and radiation therapy for solid tumors.","volume":"3","author":"Choy","year":"1996","journal-title":"Cancer Control"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2007.07.2325","article-title":"Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity.","volume":"70","author":"Safran","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0360-3016(02)02756-6","article-title":"Skin toxicity because of intensity-modulated radiotherapy for head-and-neck carcinoma.","volume":"53","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-201004000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:32Z","timestamp":1786040072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201004000-00008"}},"subtitle":["A Toxicity Analysis"],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e3181979093","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}